or Try an Advanced Search...

    Technical Analysis for ALMS - Alumis Inc.

    Grade Last Price % Change Price Change
    F 8.56 3.51% 0.29
    ALMS closed up 3.51 percent on Tuesday, December 3, 2024, on 1.8 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong N/A Down Down
    Historical ALMS trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Oversold Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 3.51%
    New 52 Week Low Weakness 3.51%
    Wide Bands Range Expansion 3.51%
    Wide Bands Range Expansion -7.56%
    NR7 Range Contraction -11.93%
    NR7-2 Range Contraction -11.93%
    Older End-of-Day Signals for ALMS ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 18 hours ago
    1.5x Volume Pace about 23 hours ago
    Up 5% about 23 hours ago
    Up 3% about 23 hours ago
    Up 2% about 23 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ALMS Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Alumis provides precision medicines. They transform the lives of patients with autoimmune diseases. They bring a proven track record in precision drug development of groundbreaking therapies. They rewrite the autoimmune treatment playbook with a unique precision analytics platform to advancing their understanding of immunologic diseases. They build a pipeline of therapeutics based on genetically validated targets for application in the treatment of multiple autoimmune disease indications.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Autoimmune Disease Drug Development Autoimmunity Syndromes Personalized Medicine Sjögren Syndrome

    Is ALMS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 28 Alumis: A Best-In-Class TYK2 Inhibitor
    Nov 14 Alumis Presents Data Highlighting ESK-001’s Potential as a High-efficacy Oral Treatment for Systemic Lupus Erythematosus (SLE) at ACR Convergence 2024
    Nov 14 Alumis reports Q3 results
    Nov 13 Alumis Reports Third Quarter 2024 Financial Results and Highlights Recent Achievements
    Nov 4 Alumis to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
    Oct 9 Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'
    Oct 4 Alumis: Could This Broken Immunology IPO Become The Next Amgen?
    Sep 27 Late-Breaking Data at EADV of ESK-001, an Oral TYK2 Inhibitor for the Treatment of Psoriasis, Demonstrate Significant Responses with Sustained Increases Over 28 Weeks in Phase 2 OLE Study
    Sep 16 Alumis: Recent IPO With Differentiated Data In Autoimmune Diseases
    Sep 3 Alumis to Participate in Upcoming September Investor Conferences
    See more ALMS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.53
    52 Week Low 8.213
    Average Volume 101,487
    200-Day Moving Average 0.00
    50-Day Moving Average 10.77
    20-Day Moving Average 10.12
    10-Day Moving Average 9.35
    Average True Range 0.87
    RSI (14) 36.31
    ADX 27.81
    +DI 11.66
    -DI 28.36
    Chandelier Exit (Long, 3 ATRs) 10.40
    Chandelier Exit (Short, 3 ATRs) 10.81
    Upper Bollinger Bands 12.67
    Lower Bollinger Band 7.57
    Percent B (%b) 0.19
    BandWidth 50.44
    MACD Line -0.67
    MACD Signal Line -0.54
    MACD Histogram -0.1288
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.55
    Resistance 3 (R3) 9.58 9.30 9.38
    Resistance 2 (R2) 9.30 9.04 9.28 9.33
    Resistance 1 (R1) 8.93 8.89 9.11 8.89 9.27
    Pivot Point 8.64 8.64 8.73 8.62 8.64
    Support 1 (S1) 8.27 8.39 8.46 8.23 7.85
    Support 2 (S2) 7.98 8.23 7.96 7.79
    Support 3 (S3) 7.61 7.98 7.74
    Support 4 (S4) 7.57